Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
about
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-RafHBV DNA Integration: Molecular Mechanisms and Clinical ImplicationsAntigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection.Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China.Impact of "a" determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B.Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs.Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma.Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection.Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV Infection.Liver lesions detected in a hepatitis B core total antibody-positive patient masquerading as hepatocellular carcinoma: a rare case of peliosis hepatis and a review of the literatureViral Biomarkers in Chronic HBeAg Negative HBV Infection
P2860
Q33648849-8D5A29B7-F864-454B-8C53-BA70E9963C5AQ38732528-E5DFF9E9-941C-47E3-A23B-D06BDA76292CQ40055980-CA0CBA19-EA40-426D-8FF4-DE29795470FEQ40165252-9CFB06EF-51D1-440E-BE11-B654B2454772Q40198363-20014993-4F60-4505-8F59-301D07B38923Q41860390-A60AF362-0A6F-4974-814D-FA288FBE7849Q45326378-F5F8E0EE-C31D-4217-B94D-AA3080CB45D6Q47559332-28FF0154-F3A6-4D30-9F6D-FEAD0DD06AF5Q49612948-00B69981-3E03-4001-B8C5-E1F5CAC7DBDBQ55429657-F4B0A0E8-4AA9-450B-BFA5-C3D628A1E810Q57652601-37FE6582-6F4A-46A1-BA12-16504E8157D0Q59126856-7F4D01A7-44E8-4D09-A8C5-2FB67F0AE36A
P2860
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Occult HBV infection in HCC an ...... irological and clinical study.
@en
Occult HBV infection in HCC an ...... irological and clinical study.
@nl
type
label
Occult HBV infection in HCC an ...... irological and clinical study.
@en
Occult HBV infection in HCC an ...... irological and clinical study.
@nl
prefLabel
Occult HBV infection in HCC an ...... irological and clinical study.
@en
Occult HBV infection in HCC an ...... irological and clinical study.
@nl
P2093
P2860
P356
P1433
P1476
Occult HBV infection in HCC an ...... virological and clinical study
@en
P2093
Carmine Minichini
Giorgio de Stefano
Giulia Liorre
Mario Starace
Nicola Coppola
Nunzia Farella
Pietro Filippini
Valentina Iodice
P2860
P304
62706-62714
P356
10.18632/ONCOTARGET.10909
P407
P577
2016-09-01T00:00:00Z